Purchase Order HHSN268201200311P

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $45,726.00 on June 23, 2011, with an ultimate completion date of August 12, 2012. The order covers maintenance and repair of instruments and laboratory equipment. Performance takes place in Bethesda, Maryland. Pricing is firm fixed price with no set-aside category applied.</p>

<p>The National Heart, Lung, and Blood Institute awarded a purchase order to Illumina, Inc. for $43,500 on November 9, 2011, with ultimate completion on November 8, 2012. The order covers maintenance, repair, and rebuild of laboratory instruments on a firm fixed price basis. Work is performed in Bethesda, Maryland.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $35,650 on November 9, 2012, for critical function and LIHA service contract to maintain scientific equipment used for clinical research. Performance is in Bethesda, Maryland. The order was scheduled for ultimate completion on November 8, 2013. Pricing is firm fixed price.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. valued at $82,758.00 on September 25, 2013, with an ultimate completion date of August 15, 2014. No set-aside was used. Work is performed in Bethesda, Maryland. The order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core portfolio of biotechnology products serving federal research and diagnostic operations.</p>

The National Heart, Lung, and Blood Institute awarded a purchase order to Illumina, Inc. for $95,569.54 on December 19, 2017, with an ultimate completion date of June 4, 2018. The order is firm fixed price, with no set-aside used. Place of performance is North Bethesda, Maryland. The purchase order covers an Illumina service contract involving sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product line for federal genomic research and diagnostic...

<p>The National Heart Lung and Blood Institute issued a $233,535.34 delivery order to Illumina, Inc. on September 3, 2014, for TruSeq SBS Kit v3–HS (200-cycle) HiSeq2000 sequencing reagents.</p> <p>Place of performance is Bethesda, MD. Ultimate completion date is August 31, 2015. The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for an MiSeq 2 sequencer assembly (catalog 15033616) valued at $95,931.00 on September 26, 2017, with completion by October 26, 2017. Performance occurs at Bethesda, Maryland 20892. The order is a firm fixed-price acquisition of this proprietary genomic sequencing instrument, no set-aside designation applied.</p>

<p>The National Heart Lung and Blood Institute issued a $23,099 delivery order to Illumina, Inc. on November 18, 2014, for genetic sequencing equipment and related supplies, with performance at Bethesda, MD and completion by August 31, 2015.</p> <p>The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $442,123.75 on December 16, 2016, to procure a comprehensive maintenance plan including parts, labor, and materials for an Illumina HiSeq 2500 sequencing instrument (serial number 7001365, NIH decal number 01696570). The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland. The maintenance plan was scheduled for completion by December 22, 2020.</p>

<p>The National Heart Lung and Blood Institute issued a $38,844 delivery order to Illumina, Inc. on November 4, 2014, for genetic sequencing and genomic analysis equipment and materials, with an ultimate completion date of August 31, 2015.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not identify the parent vehicle under which this delivery order was issued.</p>